Gps Wealth Strategies Group, LLC Arcutis Biotherapeutics, Inc. Transaction History
Gps Wealth Strategies Group, LLC
- $818 Million
- Q2 2025
A detailed history of Gps Wealth Strategies Group, LLC transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Gps Wealth Strategies Group, LLC holds 80 shares of ARQT stock, worth $1,672. This represents 0.0% of its overall portfolio holdings.
Number of Shares
80
Previous 80
-0.0%
Holding current value
$1,672
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ARQT
# of Institutions
242Shares Held
131MCall Options Held
407KPut Options Held
216K-
Suvretta Capital Management, LLC New York, NY11.5MShares$241 Million5.56% of portfolio
-
Jennison Associates LLC11.1MShares$232 Million0.09% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$225 Million3.47% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA9.87MShares$206 Million7.3% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$180 Million0.0% of portfolio
About Arcutis Biotherapeutics, Inc.
- Ticker ARQT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,187,500
- Market Cap $1.26B
- Description
- Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...